Cytotoxic T lymphocytes generated using a MYCN-derived peptide containing a HLA-A1 binding motif were able to lyse HLA-matched, MYCN-amplified neuroblastoma tumor cells in vitro [223]. Here, MYCN is linked to neuroblastoma.